Bellevue Asset Management’s Eli Lilly LLY Stock Holding History

Bellevue Asset Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$688K	Buy	574 +2	+0.3%	+$2.04K	0.32%	44
2026 Q1	$526K	Hold	572	–	–	0.26%	49
2025 Q4	$615K	Hold	572	–	–	0.2%	41
2025 Q3	$436K	Hold	572	–	–	0.2%	50
2025 Q2	$446K	Buy	572 +5	+0.9%	+$3.88K	0.22%	45
2025 Q1	$468K	Hold	567	–	–	0.26%	43
2024 Q4	$438K	Buy	567 +367	+184%	+$304K	0.23%	43
2024 Q3	$177K	Hold	200	–	–	0.09%	72
2024 Q2	$181K	Hold	200	–	–	0.1%	71
2024 Q1	$156K	Hold	200	–	–	0.09%	77
2023 Q4	$117K	Hold	200	–	–	0.1%	87
2023 Q3	$107K	Hold	200	–	–	0.07%	82
2023 Q2	$93.8K	Hold	200	–	–	0.06%	94
2023 Q1	$68.7K	Sell	200 -200	-50%	-$67.5K	0.05%	116
2022 Q4	$145K	Hold	400	–	–	0.11%	73
2022 Q3	$128K	Hold	400	–	–	0.1%	85
2022 Q2	$131K	Hold	400	–	–	0.09%	87
2022 Q1	$116K	Hold	400	–	–	0.07%	102
2021 Q4	$110K	Hold	400	–	–	0.06%	107
2021 Q3	$93K	Sell	400 -100	-20%	-$24.7K	0.06%	121
2021 Q2	$115K	Hold	500	–	–	0.07%	110
2021 Q1	$94K	Hold	500	–	–	0.06%	122
2020 Q4	$106K	Hold	500	–	–	0.06%	110
2020 Q3	$74K	Hold	500	–	–	0.05%	126
2020 Q2	$82K	Hold	500	–	–	0.08%	113
2020 Q1	$81K	Sell	500 -275	-35%	-$37.8K	0.08%	118
2019 Q4	$102K	Buy	+775	New	+$89.8K	0.08%	105

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bellevue Asset Management's LLY Position: Q2 2026 in Review

Bellevue Asset Management increased its Eli Lilly (LLY) stake by 0.35% in Q2 2026, buying an estimated $2.04K and bringing the position to 574 shares worth $688K. The position accounts for 0.32% of the portfolio, ranked #44.

Bellevue Asset Management first reported a position in LLY in Q4 2019 and has held it in 27 quarters since. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Bellevue Asset Management held 574 shares of Eli Lilly worth $688K as of Q2 2026.
Bellevue Asset Management bought 2 Eli Lilly shares in Q2 2026, an estimated $2.04K.
Eli Lilly made up 0.32% of Bellevue Asset Management's portfolio in Q2 2026, its #44 holding.
Bellevue Asset Management first reported a position in Eli Lilly in Q4 2019 and has held it in 27 quarters since.
4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Bellevue Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.